Literature DB >> 20071290

Pathogen incidence and antibiotic resistance patterns of catheter-associated urinary tract infection in children.

Xue-Cheng Bi1, Binghua Zhang, Yong-Kang Ye, Hui-Chan He, Zhao-Dong Han, Qi-Shan Dai, Yu-Xiang Liang, Guo-Hua Zeng, Yue-Sheng Wang, Qing-Biao Chen, Wei-De Zhong.   

Abstract

The aim of this study was to characterize the pathogens and their antibiotic susceptibilities in children with catheter-associated urinary tract infection (CAUTI) in order to optimize empirical antibiotic therapy and prophylaxis. from 2001 to 2006, 895 children with an indwelling catheter from 3 hospitals in China were included in this study, of whom 335 (37.4%) had CAUTI. Antimicrobial susceptibility testing of 450 bacterial isolates was performed using the ClSi broth and Kirby-bauer agar dilution methods. Escherichia coli was the most frequently isolated pathogen, followed by Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus spp. E. coli had higher susceptibility to ceftazidime (87.4%), cefuroxime (85.1%) and cefatrizine (76.6%) than to sulfamethoxazole (SMZ) (8.0%), amoxicillin (21.7%), ampicillin (17.1%) and cefazolin (37.7%). Isolates of Klebsiella pneumoniae and Proteus species had similar patterns as E. coli. S. aureus had lower susceptibility to SmZ (6.8%), ampicillin (8.2%), and amoxicillin (24.7%); the trend of S. epidermidis was similar. This study demonstrates that the Gram-negative species are the predominating uropathogens of CAUti in children. it is important to know the bacterial spectrum and the susceptibility patterns to various classes of antibiotic agents to improve empiric antibiotic therapy of children with CAUTI in China.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20071290     DOI: 10.1179/joc.2009.21.6.661

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  6 in total

1.  Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.

Authors:  Pascale S Guiton; Corinne K Cusumano; Kimberly A Kline; Karen W Dodson; Zhenfu Han; James W Janetka; Jeffrey P Henderson; Michael G Caparon; Scott J Hultgren
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

2.  Electronic surveillance for catheter-associated urinary tract infections at a university-affiliated children's hospital.

Authors:  Anita I Sen; Krystal Balzer; Diane Mangino; Maria Messina; Barbara Ross; Philip Zachariah; Lisa Saiman
Journal:  Am J Infect Control       Date:  2016-02-05       Impact factor: 2.918

3.  Bacterial uropathogens in urinary tract infection and antibiotic susceptibility pattern in jimma university specialized hospital, southwest ethiopia.

Authors:  Getenet Beyene; Wondewosen Tsegaye
Journal:  Ethiop J Health Sci       Date:  2011-07

4.  Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014.

Authors:  Qiwen Yang; Hui Zhang; Yao Wang; Zhipeng Xu; Ge Zhang; Xinxin Chen; Yingchun Xu; Bin Cao; Haishen Kong; Yuxing Ni; Yunsong Yu; Ziyong Sun; Bijie Hu; Wenxiang Huang; Yong Wang; Anhua Wu; Xianju Feng; Kang Liao; Yanping Luo; Zhidong Hu; Yunzhuo Chu; Juan Lu; Jianrong Su; Bingdong Gui; Qiong Duan; Shufang Zhang; Haifeng Shao; Robert E Badal
Journal:  BMC Infect Dis       Date:  2017-03-06       Impact factor: 3.090

5.  Phenazine-1-carboxamide functionalized mesoporous silica nanoparticles as antimicrobial coatings on silicone urethral catheters.

Authors:  Sirisha Kanugala; Sudhakar Jinka; Nagaprasad Puvvada; Rajkumar Banerjee; C Ganesh Kumar
Journal:  Sci Rep       Date:  2019-04-17       Impact factor: 4.379

6.  Catheter-associated bacterial flora in patients with benign prostatic hyperplasia: shift in antimicrobial susceptibility pattern.

Authors:  Bartosz A Dybowski; Piotr Zapała; Ewa Bres-Niewada; Łukasz Zapała; Nina Miązek-Zapała; Sławomir Poletajew; Grażyna Młynarczyk; Piotr Radziszewski
Journal:  BMC Infect Dis       Date:  2018-11-20       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.